Altimmune names Richard Menziuso principal accounting officer, global controller VP

Bitget2026/09/29 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Altimmune appointed Richard Menziuso as vice president, global controller, principal accounting officer, effective Sept. 29, 2026.
Menziuso previously served as vice president, corporate controller at Centessa Pharmaceuticals from 2021 until its 2026 acquisition by Eli Lilly.
Earlier roles included finance leadership posts at Thermo Fisher Scientific, Axovant Gene Therapies, PricewaterhouseCoopers, Bristol-Myers Squibb.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001326190-26-000056), on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Altimmune names Richard Menziuso principal accounting officer, global controller VP

You may also like

Crypto prices